Prochlorperazine 5 MG/ML Injectable Solution — RxCUI 2102949
RxNorm drug concept · Semantic clinical drug
RxCUI 2102949
Semantic clinical drug · SCD
● Current RxNorm concept 14 FDA products
21 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2102949
Official nameProchlorperazine 5 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asprochlorperazine (as edisylate) 5 MG/ML Injectable Solution
FDA products mapped14
Package NDCs mapped21
Reported Medicaid activity (SDUD)59,546 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Prochlorperazine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Prochlorperazine is most commonly used to control severe nausea and vomiting. Depending on the form your doctor prescribed, it may also be used to treat schizophrenia. The tablet f...
- What is prochlorperazine actually used for?
- The most common ones are drowsiness, dizziness, blurred vision, and a drop in blood pressure when you stand up quickly. More serious — but less common — reactions include uncontrol...
- What side effects should I watch out for?
🕸️ Concept Web — How Prochlorperazine 5 MG/ML Injectable Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Prochlorperazine 5 MG/ML Injectable Solution
RxCUI 2102949 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Prochlorperazine
8704IN
-
Prochlorperazine
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Prochlorperazine Injectable Solution
373605SCDF -
Prochlorperazine Injectable Product
1161738SCDG -
Injectable Solution
316949DF -
Injectable Product
1151126DFG
-
Prochlorperazine Injectable Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Prochlorperazine 5 MG/ML
316597SCDC
-
Prochlorperazine 5 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Prochlorperazine 5 MG/ML
SCDC · 316597 -
Prochlorperazine Injectable Solution
SCDF · 373605 -
Prochlorperazine Injectable Product
SCDG · 1161738
📦 FDA Products & Package NDCs
14 products · 21 package NDCs
21 package NDCs map to RxCUI 2102949 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00713-0351-09 | 10 VIAL in 1 PACKAGE (0713-0351-09) / 2 mL in 1 VIAL (0713-... | Prochlorperazine Edisylate | Cosette Pharmaceuticals, Inc. | 2022-02-11 |
| 00713-0351-25 | 25 VIAL in 1 PACKAGE (0713-0351-25) / 2 mL in 1 VIAL (0713-... | Prochlorperazine Edisylate | Cosette Pharmaceuticals, Inc. | 2022-02-11 |
| 23155-0294-41 | 25 VIAL in 1 PACKAGE (23155-294-41) / 2 mL in 1 VIAL (23155... | Prochlorperazine Edisylate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2012-03-26 |
| 23155-0294-42 | 10 VIAL in 1 PACKAGE (23155-294-42) / 2 mL in 1 VIAL (23155... | Prochlorperazine Edisylate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2012-03-26 |
| 23155-0523-41 | 10 VIAL in 1 PACKAGE (23155-523-41) / 2 mL in 1 VIAL (23155... | Prochlorperazine Edisylate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2015-06-26 |
| 23155-0523-42 | 25 VIAL in 1 PACKAGE (23155-523-42) / 2 mL in 1 VIAL (23155... | Prochlorperazine Edisylate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2015-06-26 |
| 25021-0790-02 | 10 VIAL in 1 CARTON (25021-790-02) / 2 mL in 1 VIAL | PROCHLORPERAZINE EDISYLATE | Sagent Pharmaceuticals | 2021-11-15 |
| 25021-0790-03 | 25 VIAL in 1 CARTON (25021-790-03) / 2 mL in 1 VIAL | PROCHLORPERAZINE EDISYLATE | Sagent Pharmaceuticals | 2021-11-15 |
| 43066-0090-25 | 25 VIAL in 1 CARTON (43066-090-25) / 2 mL in 1 VIAL (43066-... | PROCHLORPERAZINE EDISYLATE | Baxter Healthcare Corporation | 2021-05-03 |
| 51662-1558-03 | 25 POUCH in 1 CASE (51662-1558-3) / 1 VIAL in 1 POUCH (5166... | PROCHLORPERAZINE EDISYLATE | HF Acquisition Co LLC, DBA HealthFirst | 2022-06-15 |
| 55150-0360-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-360-01) / 2 mL in 1 V... | Prochlorperazine Edisylate | Eugia US LLC | 2022-07-14 |
| 55150-0360-25 | 25 VIAL, MULTI-DOSE in 1 CARTON (55150-360-25) / 2 mL in 1... | Prochlorperazine Edisylate | Eugia US LLC | 2022-07-14 |
| 65145-0119-10 | 10 VIAL in 1 CARTON (65145-119-10) / 2 mL in 1 VIAL (65145-... | Prochlorperazine Edisylate | Caplin Steriles Limited | 2026-04-08 |
| 68083-0435-10 | 10 VIAL in 1 CARTON (68083-435-10) / 2 mL in 1 VIAL (68083-... | Prochlorperazine Edisylate | Gland Pharma Limited | 2021-09-22 |
| 68083-0435-25 | 25 VIAL in 1 CARTON (68083-435-25) / 2 mL in 1 VIAL (68083-... | Prochlorperazine Edisylate | Gland Pharma Limited | 2021-09-22 |
| 68083-0436-01 | 1 VIAL in 1 CARTON (68083-436-01) / 10 mL in 1 VIAL | Prochlorperazine Edisylate | Gland Pharma Limited | 2021-09-22 |
| 70069-0371-25 | 25 VIAL in 1 CARTON (70069-371-25) / 2 mL in 1 VIAL (70069-... | Prochlorperazine Edisylate | Somerset Therapeutics, LLC | 2024-10-10 |
| 70121-1580-05 | 25 VIAL in 1 CARTON (70121-1580-5) / 2 mL in 1 VIAL (70121-... | prochlorperazine edisylate | Amneal Pharmaceuticals LLC | 2022-12-12 |
| 70121-1580-07 | 10 VIAL in 1 CARTON (70121-1580-7) / 2 mL in 1 VIAL (70121-... | prochlorperazine edisylate | Amneal Pharmaceuticals LLC | 2022-12-12 |
| 72266-0204-10 | 10 VIAL in 1 CARTON (72266-204-10) / 2 mL in 1 VIAL (72266-... | Prochlorperazine Edisylate | FOSUN PHARMA USA INC | 2023-05-01 |
| 83634-0778-02 | 10 VIAL in 1 CARTON (83634-778-02) / 2 mL in 1 VIAL (83634-... | prochlorperazine edisylate | Avenacy Inc. | 2024-06-01 |
Observed labelers:
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (4) ·
Gland Pharma Limited (3) ·
Amneal Pharmaceuticals LLC (2) ·
Cosette Pharmaceuticals, Inc. (2) ·
Eugia US LLC (2) ·
Sagent Pharmaceuticals (2)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J0780 | Prochlorperazine injection | 11 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.